Drug
Oritavancin
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Infusion Related Reaction | 61 | 21.3 | 22.7 | signal |
| 2 | Chills | 88 | 17.2 | 19.0 | signal |
| 3 | Agranulocytosis | 12 | 14.9 | 15.1 | signal |
| 4 | Urticaria | 105 | 14.5 | 16.3 | signal |
| 5 | Pruritus Generalised | 13 | 13.6 | 13.8 | signal |
| 6 | Anaphylactic Reaction | 26 | 10.9 | 11.2 | signal |
| 7 | Feeling Cold | 13 | 10.7 | 10.9 | signal |
| 8 | Rash Generalised | 12 | 10.5 | 10.6 | signal |
| 9 | Pruritus | 162 | 9.9 | 11.8 | signal |
| 10 | Flushing | 41 | 9.2 | 9.6 | signal |
| 11 | Incorrect Product Administration Duration | 8 | 9.1 | 9.1 | signal |
| 12 | Respiratory Depression | 4 | 7.5 | 7.5 | signal |
| 13 | No Adverse Event | 37 | 4.8 | 5.0 | signal |